Takeda Pharmaceutical Company Limited is to invest €40m in a new facility at their Grange Castle site in Dublin.
Takeda is the largest pharmaceutical company in Japan and a global industry leader. The company first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002, Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan.
The investment by Takeda will expand their Grange Castle site’s existing footprint with the construction of a new standalone high containment production facility dedicated to manufacturing its oncology product NINLAROTM for global markets. The investment will create approximately 40 new jobs.
“We are delighted that Takeda has chosen Ireland for this investment and proud that we have been entrusted with the responsibility to produce and deliver this very important treatment for cancer patients worldwide. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site”.
Mr. Paul Keogh, Plant Director at Takeda Ireland Grange Castle
Upload your CV to apply for as many jobs as you like.upload your CV